Hydralazine HCL 100mg Tablet Manufacturing and Supply
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This contract involves the full-scale manufacturing and supply of Hydralazine HCL 100mg tablets, covering all aspects from formulation to packaging, labeling, and final delivery. The finished products are to be supplied to VA Prime Vendor distribution centers, ensuring availability for the Department of Veterans Affairs. The contract falls under NAICS code 325412, indicating it is related to pharmaceutical preparation manufacturing. Issued by Nac Pharmaceuticals on behalf of the Department of Veterans Affairs, the subcontract was posted on February 4, 2026. While specific details such as solicitation number, place of performance, and point of contact are not provided, the contract underscores a comprehensive scope to support the VA’s pharmaceutical supply chain with consistent production and timely delivery of this critical medication.
General Info
Agency
NAICS
Place of Performance
ILSet-Aside
Documents
This scope was carved out of 36e79725R0060.
The full solicitation package (4 documents), including the RFP, is on the prime solicitation, not on this scope.
6505--Hydralazine HCL Tablets Effective 04/08/2026 to 04/07/2027
AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)
Same awarding agency
